Acute megakaryoblastic leukemia (AMKL) is a cytological subgroup of acute myeloid leukemia (AML) that harbors megakaryocytic lineage markers (eg, CD41, CD42, and CD61). AMKL occurrence is almost entirely restricted to children (usually < 3 years of age), occurring in only 1% of adult AML cases, often after progression from myelodysplastic syndromes. AMKL represents ∼10% of pediatricContinue reading “What is AMKL”
Sonia Cellot Laboratory 